Does NEFOPAM Cause Chronic obstructive pulmonary disease? 9 Reports in FDA Database

Q: Does NEFOPAM cause Chronic obstructive pulmonary disease?

9 reports of Chronic obstructive pulmonary disease have been filed with the FDA for NEFOPAM, representing 0.3% of all NEFOPAM adverse event reports.

Q: How dangerous is Chronic obstructive pulmonary disease from NEFOPAM?

Of 9 reports, 9 (100.0%) resulted in death and 8 required hospitalization.

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Chronic obstructive pulmonary disease have been filed in association with NEFOPAM. This represents 0.3% of all adverse event reports for NEFOPAM.

Reports of Chronic obstructive pulmonary disease with NEFOPAM

0.3%

of all NEFOPAM reports

Deaths

Hospitalizations

How Dangerous Is Chronic obstructive pulmonary disease From NEFOPAM?

Of the 9 reports, 9 (100.0%) resulted in death, 8 (88.9%) required hospitalization, and 9 (100.0%) were considered life-threatening.

Is Chronic obstructive pulmonary disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NEFOPAM. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does NEFOPAM Cause?

Cholestasis (135) Confusional state (134) Acute kidney injury (130) Hepatocellular injury (107) Hepatic cytolysis (101) Eosinophilia (97) Rash maculo-papular (97) Drug reaction with eosinophilia and systemic symptoms (90) Coma (86) Somnolence (84)

What Other Drugs Cause Chronic obstructive pulmonary disease?

ALBUTEROL (2,916) TIOTROPIUM (2,895) BUDESONIDE\FORMOTEROL (2,279) FLUTICASONE\SALMETEROL (1,904) ADALIMUMAB (1,712) PREDNISONE (1,237) FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145) MEPOLIZUMAB (1,107) FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967) DUPILUMAB (907)

Which NEFOPAM Alternatives Have Lower Chronic obstructive pulmonary disease Risk?

NEFOPAM vs NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE\NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIG NEFOPAM vs NELARABINE NEFOPAM vs NELFINAVIR NEFOPAM vs NELVUTAMIG NEFOPAM vs NEMOLIZUMAB

NEFOPAM Full Profile All Chronic obstructive pulmonary disease Reports All Drugs Causing Chronic obstructive pulmonary disease NEFOPAM Demographics